A carregar...
Cardioprotective effects of GLP‐1(28‐36a): A degraded metabolite or GLP‐1’s better half?
Molecular mechanism underlying glucagon‐like peptide‐1 exertion of cardioprotective effects in glucagon‐like peptide‐1 receptor‐dependent and ‐independent manners. Glucagon‐like peptide‐1 (28‐36a) enters coronary artery endothelial cells through macropinocytosis and binds to mitochondrial trifunctio...
Na minha lista:
| Publicado no: | J Diabetes Investig |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7610112/ https://ncbi.nlm.nih.gov/pubmed/32428993 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13302 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|